Eli Lilly and Co/ US5324571083 /
2024-05-10 9:59:55 PM | Chg. -11.29 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
760.25USD | -1.46% | 80,427 Turnover: 61.51 mill. |
-Bid Size: - | -Ask Size: - | 722.31 bill.USD | 0.62% | 130.58 |
GlobeNewswire
05-08
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
05-08
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire
05-01
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-29
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
04-26
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
04-22
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
GlobeNewswire
04-22
TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology...
GlobeNewswire
04-17
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
GlobeNewswire
04-15
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...
GlobeNewswire
04-10
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atop...
GlobeNewswire
04-02
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
03-28
Governor Holcomb, IEDC Secure Largest Quarter of Committed Capital Investment in State History